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Abstract
Background. This study aimed to develop, validate and compare the performance of models
predicting post-treatment outcomes for depressed adults based on pre-treatment data.
Methods. Individual patient data from all six eligible randomised controlled trials were used
to develop (k = 3, n = 1722) and test (k = 3, n = 918) nine models. Predictors included depres-
sive and anxiety symptoms, social support, life events and alcohol use. Weighted sum
scores were developed using coefficient weights derived from network centrality statistics
(models 1–3) and factor loadings from a confirmatory factor analysis (model 4).
Unweighted sum score models were tested using elastic net regularised (ENR) and ordinary
least squares (OLS) regression (models 5 and 6). Individual items were then included in
ENR and OLS (models 7 and 8). All models were compared to one another and to a null
model (mean post-baseline Beck Depression Inventory Second Edition (BDI-II) score in
the training data: model 9). Primary outcome: BDI-II scores at 3–4 months.
Results. Models 1–7 all outperformed the null model and model 8. Model performance was
very similar across models 1–6, meaning that differential weights applied to the baseline sum
scores had little impact.
Conclusions. Any of the modelling techniques (models 1–7) could be used to inform prog-
nostic predictions for depressed adults with differences in the proportions of patients reaching
remission based on the predicted severity of depressive symptoms post-treatment. However,
the majority of variance in prognosis remained unexplained. It may be necessary to include
a broader range of biopsychosocial variables to better adjudicate between competing models,
and to derive models with greater clinical utility for treatment-seeking adults with depression.
Introduction
Depression affects ∼320 million people worldwide every year (Thornicroft et al., 2017; Vos
et al., 2016). Despite the existence of effective treatments, roughly half of depressed patients
do not recover with the first treatment they are given. This can lead to disengagement and
poor long-term prognoses (Buckman et al., 2018; Judd et al., 1998). Providing accurate predic-
tions about the likelihood of treatment response for patients would be of great value, inform-
ing clinical management and giving patients and clinicians desired information (Hayden,
Windt Van Der, Cartwright, Côté, & Bombardier, 2013; Morgan, Reavley, & Jorm, 2014).
However, there are a lack of accurate, validated prognostic models for adults in treatment
for depression (Cohen & DeRubeis, 2018). Central to this vacancy in the literature are
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methodological inconsistencies, debates about how best to
develop predictive models, and what variables to include in
such models. Recently, the field has begun to reach consensus
on how to best test the utility of predictive models, for example,
by evaluating them in datasets that are separate from those used
for model development (Adibi, Sadatsafavi, & Ioannidis, 2020;
Dwyer, Falkai, & Koutsouleris, 2018; Harrell, Lee, & Mark,
2004; Moons et al., 2015; Steyerberg et al., 2010).
One factor consistently found to be associated with prognosis
of depression is the severity of depressive symptoms pre-treatment
(Bower et al., 2013; Driessen, Cuijpers, Hollon, & Dekker, 2010;
Fournier, Derubeis, Hollon, Shelton, & Fawcett, 2010; Weitz
et al., 2015). This is often captured with sum scores on depressive
symptom scales. However, depression is heterogeneous (Fried &
Nesse, 2015a) so utilising symptom level data might provide
more nuanced information on patients experiences of depression,
and consequently improve the accuracy of prognostic predictions
(Boschloo, van Borkulo, Borsboom, & Schoevers, 2016; Fava,
Ruini, & Belaise, 2007; Fried & Nesse, 2014, 2015b). Network the-
ory (Borsboom & Cramer, 2013; Fried & Cramer, 2017) has given
rise to an approach that can capture the relationships between
individual symptoms. These relationships could reflect potential
causal pathways, thereby elucidating maintenance mechanisms
that could be targeted with treatment, and might therefore inform
prognosis (Borsboom, 2017). The arrangement and inter-
relationships of symptoms within networks have most often
been captured with one or more measures of centrality – i.e.
the interconnectedness of each symptom with other symptoms
in the network (Bringmann et al., 2019; Fried, Epskamp, Nesse,
Tuerlinckx, & Borsboom, 2016).
A recent study used centrality metrics to weight individual
items of a depressive symptom questionnaire, which when
summed together created a new, or weighted, sum score. A regres-
sion model using this weighted sum score was found to outper-
form a model containing the original sum score in an
exploratory analysis (Boschloo et al., 2016). Other studies have
utilised centrality metrics to predict changes in particular symp-
toms over time (Boschloo et al., 2016; Koenders et al., 2015;
van Borkulo et al., 2015; Wichers & Groot, 2016), or predict post-
treatment outcomes (Berlim, Richard-Devantoy, Dos Santos, &
Turecki, 2020; Elliott, Jones, & Schmidt, 2020). However, such
studies have not tested the developed models against simpler
comparative models, nor have they tested the predictive utility
of the models in completely external data (Dwyer et al., 2018;
Harrell et al., 2004; Webb et al., 2020), or adhered to recent con-
ventions for the transparency of conducting such research by fol-
lowing pre-registered analysis plans or protocols (Collins,
Reitsma, Altman, & Moons, 2015). Therefore, the extent to
which the use of centrality metrics can add incremental value
in prognostic models remains unclear. The present paper aims
to fill this gap and further the consideration of the development
of models that can be translated into clinical settings.
There are several potentially equally valid ways to estimate
item centrality in network models. We will therefore investigate
several methods that have been used in the recent network mod-
elling literature. One method uses the estimated arrangement of
items into communities of highly partially correlated items, we
will compare this to a model in which it is assumed that there is
a single latent factor. We will use these methods to investigate
the benefit of using item centrality scores and factor loadings to
create weighted sum scores, and compare these to an unweighted
regression model, and to a penalised regression model, as these
are typical methods used to develop predictive models. We will
then compare all of these methods against models that use all
the individual items rather than sum scores, and to a simple null
model (Boschloo et al., 2016). In this way, this study aims to
develop, validate and compare the predictive performance of prog-
nostic models for depressed adults in primary care, based on pre-
treatment data including individual symptoms of depression.
Methods
The methods for the present study were pre-registered (https://osf.
io/vzk65/). We have reported the details in accordance with
TRIPOD, brief details are given below, and further information
including a TRIPOD checklist is available in the online
Supplementary materials.
Ethical considerations and trial registrations
All included studies were granted ethical approvals and all parti-
cipants gave informed consent (online Supplementary Table S5).
No additional NHS ethical approval was required for this study:
HRA reference 712/86/32/81.
Participants
The dataset for this study comes from a larger project investigat-
ing prognosis for adults with depression in primary care, the pro-
ject involved systematic literature searches to form an individual
patient dataset (IPD) from eligible randomised controlled trials
(RCTs; Buckman et al., 2020). The final searches were conducted
on 1 December 2020 (Buckman et al., 2021b). Studies were
included if they were RCTs that recruited adults with depression
in primary care, and used the Revised Clinical Interview Schedule
(CIS-R) (Lewis, Pelosi, Araya, & Dunn, 1992) to collect depressive
and anxiety symptom data and determine diagnoses. This was to
ensure uniformity across the studies in the items available for the
predictive models. Fromour previous workwe found that the CIS-R
is the most commonly used comprehensive measure of this kind in
studies of depression in primary care (Buckman et al., 2021a).
Studies also had to use the Beck Depression Inventory Second
Edition (BDI-II) (Beck, Steer, & Brown, 1996) to collect individual
symptoms of depression. Six RCTs met inclusion criteria and were
split such that half (k = 3, n = 1722) would form a dataset to develop
the predictive models (the ‘training set’) and half (k = 3, n = 1136, of
which 918 had outcome data andwere used to evaluate themodels as
detailed below) would form a separate dataset to test the models (the
‘test set’). See online Supplementary Table S1 and Supplementary
Fig. S1, for details of each study. It was decided that studieswith simi-
lar types of treatments would be split across the training and test sets
(with all data from one study going into the training set and all data
from the other study going into the test set), and where this was the
case, those with the larger sample sizes would go into the training
data.
Predictors and measures
Predictors varied depending on the model used, as detailed below
(Table 1). Models either included total scores (with items either
weighted or unweighted) or individual items from the BDI-II.
All models used total scores for the eight anxiety subscales
from CIS-R (generalised anxiety, worry, compulsions, obsessions,
phobic anxiety, health anxiety, somatic concerns, and panic; with
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items either weighted or unweighted), and total scores for alcohol
use, social support and life events. In previous studies using similar
data it has been found that these factors are independently associated
with poorer prognoses, and may have utility in predicting treatment
outcomes (Buckman et al., 2021a; Buckman et al., 2021b; O’Driscoll
et al., 2021). The total scores for the social support, life events and
alcohol measures were required instead of the individual items.
There was strong topological overlap between the social support
items, and all eight items were highly correlated with one another,
which would have led to inflated centrality scores were the individual
items included in the network models. Further, the level of multi-
collinearity went beyond pairs of items, so instead of removing
those leading to high multi-collinearity, it was necessary to use the
sum score as the best measure of this construct. Modelling binary
items into a network is possible but not when using the fused graph-
ical least absolute shrinkage and selection operator (LASSO) (FGL)
method adopted here to deal with between-study heterogeneity, so
the total score from the life events scale was used. As alcohol misuse
was an exclusion criterion for some of the eligible RCTs, there was
near zero variability for many of the items. The sum score therefore
represented the best measure of alcohol use.
The null models used the BDI-II total score only. See online
Supplementary Table S2 for details of the measures.
Outcomes
The primary outcome was the BDI-II score at 3–4 months post-
baseline. The secondary outcome was remission at 3–4 months
post-baseline, defined as a score of ⩽10 on the BDI-II. In all
but one of the six studies, assessors and analysts were blind to
treatment allocation when collecting these data.
Data analysis
Missing data were imputed in the training set for all variables with
<30% missing, using the ‘missForest’ package in R (Stekhoven &
Bühlmann, 2012). In the test set, the same approach was used but
outcome data were not imputed. The maximum amount of miss-
ing data of any of the variables used in the predictive models here,
at baseline in any of the six studies was 0.83%. In the test set, 218
participants were missing outcome data and were excluded from
the analyses. For one study whose data were included in the train-
ing set, ‘COBALT’, BDI-II was not collected at 3–4 months. These
scores were imputed using the methods above based on all avail-
able variables in that study including baseline BDI-II scores and
patient health questionnaire-9 (PHQ-9) scores, 3-month PHQ-9
scores, 6-month BDI-II and PHQ-9 scores, and 12-month
BDI-II and PHQ-9 scores (see online Supplementary for
additional details).
Model building
Nine models were constructed in the training set (Table 1) for
both primary and secondary outcomes, so 18 models were fitted
overall.
For the first four models, we developed separate weighted sum
scores for the CIS-R anxiety subscales by summing together











1 OLS CIS-R weighted sum score for anxiety
subscales, BDI-II weighted score, SSS
score, LE score and AUDIT-PC score
Sum of all edges connected to the focal




2 OLS CIS-R weighted sum score for anxiety
subscales, BDI-II weighted score, SSS
score, LE score and AUDIT-PC score
Sum of all edges connected to either the
focal node or any other node directly
connected to the focal node
PC/PR (FGL) 3 OLS CIS-R weighted sum score for anxiety
subscales, BDI-II weighted score, SSS
score, LE score and AUDIT-PC score
the geometric mean between the
participation coefficient (PC) and
participation ratio (PR)
CFA 4 OLS CIS-R weighted sum score for anxiety
subscales, BDI-II weighted score, SSS
score, LE score and AUDIT-PC score
Factor loadings from CFA were used as




Shrinkage 5 ENR CIS-R unweighted sum score for
anxiety subscales, BDI-II score, SSS
score, LE score and AUDIT-PC score
ENR built using the unweighted total
scores
None 6 OLS CIS-R unweighted sum score for
anxiety subscales, BDI-II score, SSS
score, LE score and AUDIT-PC score
OLS model with unweighted total scores
on the baseline measures
Individual
symptoms
Shrinkage 7 ENR CIS-R anxiety subscale items, BDI-II
individual items, SSS score, LE score
and AUDIT-PC score
ENR model using all of the individual
items of BDI-II, anxiety sub-scores of
CIS-R and total scores of other measures
None 8 OLS CIS-R anxiety subscale items, BDI-II
individual items, SSS score, LE score
and AUDIT-PC score
OLS regression model with items
assessing the same symptoms included
in weighted models.
Null model None 9 OLS Mean BDI-II sum score Mean BDI-II score in training set studies
used as prediction for all cases in test set
BDI-II, Beck Depression Inventory Second Edition; CFA, confirmatory factor analysis; CIS-R, Revised Clinical Interview Schedule; EI, expected influence; ENR, elastic net regularised regression;
FGL, fused graphical LASSO; LE, life events; OLS, ordinary least squares; PC/PR, geometric mean between the participation ratio and participation coefficient; SSS, social support scale.
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coefficient weights for each of the eight subscales, and for the
BDI-II by summing together coefficient weights for each of the
21 BDI-II items. Weighted sum scores for the CIS-R anxiety sub-
scales and BDI-II, and coefficient weights for the total scores for
social support, life events, and alcohol were used as predictors by
entering them into regression models (ordinary least squares
(OLS) for the primary outcome and logistic regression for the sec-
ondary outcome). This follows a method used by others to
develop predictive models from networks (Boschloo et al.,
2016). As described below, models 5 and 7 were based on a
method that develops model weights internally (elastic net regu-
larised regression (ENR)). Models 6 and 8 used the original,
unweighted scores as a means of comparison. Model 9 was a
null model, detailed further below.
Network analyses
There are two established ways to estimate a network model
across several datasets. First, pool the data and estimate a
model. Second, a recent innovation in network methods, the
FGL (Costantini & Epskamp, 2017b; Fried et al., 2018), which
estimates a model on several datasets and obtains one network.
The FGL uses extended Bayesian information criterion, LASSO
regularised regression models run separately for each study, and
the models are then fused together to get a single network pena-
lising differences among corresponding edge weights in the study
networks. It is therefore considered better suited to deal with
between-study heterogeneity (Costantini et al., 2019), and so
was the method used here. For further details on how to estimate
and interpret network structures and a comprehensive review of
the network literature (see Epskamp & Fried, 2018; Robinaugh,
Hoekstra, Toner, & Borsboom, 2020). For models 1–3, the FGL
model was estimated using item-level data from CIS-R anxiety
subscales and the BDI-II with tuning parameters selected through
10-fold cross validation (Costantini & Epskamp, 2017a; Danaher,
Wang, & Witten, 2014). Centrality metrics derived from the FGL
were used to construct weights after re-scaling these to be between
0 and 1. The three methods for determining coefficient weights
from the estimated networks were: model (1) one-step expected
influence (EI: sum of all edges connected to the focal node);
model (2) two-step EI (sum of all edges connected to either the
focal node or any other node directly connected to the focal
node) (Robinaugh, Millner, & McNally, 2016); and model (3)
the geometric mean of the participation coefficient (PC) and par-
ticipation ratio (PR) (Letina, Blanken, Deserno, & Borsboom,
2019). See online Supplementary materials for details. The EI
metrics are widely used and have recently been proposed to be
informative for predicting treatment outcomes (Berlim et al.,
2020; Elliott et al., 2020). PC/PR is a newer approach, which is
thought to be more sensitive to the use of different scale measures
within the same network as it takes the community structure
(multidimensionality) into account (Letina et al., 2019). This is
important here as we used measures of severity beyond depressive
symptoms, given their importance for prognosis (Buckman et al.,
2021a; Lorenzo-Luaces, Rodriguez-Quintana, & Bailey, 2020).
Confirmatory factor analyses
Model 4 was a unidimensional confirmatory factor analytic (CFA)
model that assumes the data come from a single dimensional
latent construct (in contrast to model 3, which is based on a
Walktrap algorithm that identifies densely connected
communities of items via random walks). Factor loadings were
rescaled to be between 0 and 1 and summed to develop the
weighted total scores.
Penalised regression analyses
Model 5 was an ENR model built using the unweighted total
scores on the same scales that were used for models 1–4. In
ENR, variables are selected and model weights are assigned
through the use of LASSO and ridge penalisations. Parameter
space was searched using 10-fold cross-validation to identify the
optimal settings for these parameters before building the final
model (Friedman, Hastie, & Tibshirani, 2010; Webb et al.,
2020). Model 7 was an ENR using all of the individual items
from the BDI-II and the CIS-R anxiety subscales, and total scores
for life events, social support and alcohol use.
Non-penalised regression analyses
Two simple comparison models were constructed using non-
penalised regression (OLS regression for continuous outcomes
and logistic regression for binary outcomes). Model 6 used the
unweighted total scores on the five baseline measures, and
model 8 used the same items as model 7.
Null models
A null model was built for each outcome for the purpose of com-
parison. For the primary outcome, this used the mean 3–4-month
BDI-II score in the training set as the prediction for all patients in
the test set, and for the secondary outcome the proportion of par-
ticipants in remission in the training set was used as the predic-
tion for all patients in the test set.
Sensitivity analyses
In order to assess the impact of having to impute the 3–4-month
BDI-II outcomes for the COBALT study, we conducted two sen-
sitivity analyses. All analyses using BDI-II as the outcome were
re-done excluding COBALT from the training dataset. Then, a
different way of capturing depressive symptoms at 3–4 months
was calculated based on a method of converting scores from dif-
ferent depressive symptom measures to a single comparable score;
the PROMIS T-score (Choi, Schalet, Cook, & Cella, 2014), using a
multidimensional item-response theory-based conversion tool
(Fischer & Rose, 2016), see online Supplementary for further
details.
Model evaluation
Models were first evaluated in the full test set comprising three
studies (TREAD, IPCRESS and MIR), and then separately in
each of the three study samples. They were also evaluated in a
10-fold internal cross-validation of the full training set data.
For the continuous outcomes, there were three metrics used to
evaluate the models: the amount of variance explained (R2), the
root mean-squared error (RMSE), and the mean absolute error
(MAE). For the binary outcome, there were two metrics used to
evaluate the models: the area under the receiver operating charac-
teristic curve, and Brier scores. Since the R2 in this study is a com-
parison of the predicted BDI-II score values to the mean BDI-II
score at 3–4 months in the test set, and the training and test set
4 J. E. J. Buckman et al.
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BDI-II score means at 3–4 months differed, it was expected that
some models might have R2 values less than zero. There are limits
to the inferences that can be drawn from the above metrics due to
the variability in the modelling schemes that were applied (e.g. in
which variables were made available; the number of variables
made available; whether or not network analysis or factor analysis
was used to create weighted sum scores; and whether or not pena-
lised regression was applied to the variables that were made avail-
able). To make these performance metrics more accessible, we have
provided three visualisations that demonstrate the potential clinical
relevance of each model. For each of the eight models (excluding
the null model) the predicted BDI-II scores at 3–4 months were
arrayed from the lowest to the highest, then: (1) we plotted the
observed BDI-II score at 3–4 months against the predicted score
in groups (‘bins’) of n = 50; (2) predicted scores were split into cat-
egories of severity in line with delineations made by the originators
of the scale (Beck et al., 1996) (i.e. scores between 0 and 13 were
considered minimal, 14 and 19 mild, 20 and 28 moderate, and
29 and 63 severe), and the rate of remission observed in the test
set samples was calculated for each category; and (3) to provide a
more granular visualisation of remission we plotted the observed
percentage of participants in remission against BDI-II predicted
scores at 3–4 months, again in bins of n = 50.
Results
Characteristics of the included studies
Six RCTs met inclusion criteria, three formed the training dataset
(n = 1772) and three formed the test dataset (n = 1136, of which
n = 918 had outcome data available for analyses), see online
Supplementary Fig. S1 for flow of studies and online
Supplementary Table S1 for details of each study.
Descriptive statistics
Descriptive statistics and comparisons of the distributions of
socio-demographics and markers of severity across the training
set and test set samples are provided in Table 2. There were
some differences between the training and test datasets: fewer
people of non-White ethnicities were in the test set, and more
of the training sample were unemployed. On average the test set
participants had more comorbid disorders although a higher pro-
portion of the training set sample had comorbid panic disorder,
specific phobias, or chronic fatigue syndrome. The mean score
on the AUDIT-PC was higher in the test set. In addition, the
mean BDI-II scores were higher in the test set (by 2.47 points
at baseline and 3.53 points at 3–4 months). This corresponded
with a large difference in the proportions of each sample reaching
remission: 48.83% in the training set and 32.53% in the test set.
Formation of the models
The weights given to the individual items for models 1–4 are
shown in online Supplementary Table S6. Final model coefficients
are presented in online Supplementary Tables S7 and S8.
Comparison of model performance
After the models were developed they were evaluated using
the test dataset. Despite slight differences in the formation of
some of the models, they made very similar predictions of who
would get better (remit) and by what magnitude (BDI-II score)
at 3–4 months. To illustrate this, the predictions produced for
the primary outcome by the models were highly correlated (all
correlation coefficients above r = 0.90 for models 1–6 and above
r = 0.75 for models 7–8) see online Supplementary Fig. S2.
For the primary outcome (BDI-II score at 3–4 months post-
baseline) in the combined test sets, the RMSE was similar for
models 1–6 (the largest difference was between model 2 which
had the lowest RMSE and model 4, =0.057) with a slightly higher
RMSE for the OLS individual-item model (model 8) (difference
between model 2 and model 8 = 0.214). Models 1–8 made similar
predictions for those with BDI-II scores at 3–4 months that were
<18 or >25, but diverged more in the predictions for those with
scores between 18 and 24, see Fig. 1 (for ease of presentation,
results are displayed for groups of 50 participants, each point
shows the mean predicted and observed score for the 50 partici-
pants closest to that point on the graph). All models (1–8) had
lower RMSE scores than the null model (ranging from 0.944 for
the difference between models 8 and 9 to 1.158 for the difference
between models 2 and 9), see Table 3. The amount of variance
explained by models 1–7 was again very similar with R2 values
between 0.157 and 0.169. Model 8 (R2 = 0.109) explained less
variance, but all models had R2 values well above the null
model (R2 = −0.01). MAE values were similar for models 1–7
(ranging between 9.089 for model 5 and 9.173 for model 7).
MAE was slightly higher in model 8 (=9.279) and higher again
in the null model (9.935), see Table 3. For the secondary outcome
there was a similar pattern to the results, although the null model
(9) had a similar Brier score to models 1–7 and this was slightly
lower than that of model 8 (=0.246), see online Supplementary
Table S3. There were greater variations between the models in
the separate test set studies than in the overall test set and for
all models (1–9). Additionally, the RMSE and MAE scores were
lower, and R2s were higher, in the internal cross-validation than
in the external test set data.
In order to evaluate the potential clinical relevance of the mod-
els we determined the observed proportion of participants in
remission at 3–4 months based on the predicted score made by
each model (online Supplementary Fig. S3), and the same based
on categories of severity of symptoms taken from the predicted
scores (see Fig. 2). From these figures we can see that when the
models predicted high BDI-II scores at 3–4 months the chances
of being in remission were very low. Models 7 and 8 predicted
more participants would have severe depression at 3–4 months
than the other models. When the models predicted minimal
symptoms (BDI-II scores <10) the observed rate of remission
was around 50%. There were few differences between the models
overall, although greater variations in the observed rates of remis-
sion between the models for patients predicted to have mild to
moderate BDI-II scores at 3–4 months.
Sensitivity analyses did not lead to any substantive differences
in our findings, see online Supplementary Tables S2 and S3.
Discussion
There were few differences in the performance of the majority of
the predictive models. The first seven models all outperformed the
null models on all metrics for primary and secondary outcomes.
Those using weighted or unweighted sum scores (the first six
models) performed better in the held-out test data than the
individual-item models did, particularly model 8 (the OLS regres-
sion model using all of the individual BDI-II score items and
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Table 2. Descriptive statistics for training and test set samples, and comparison of the two datasets
Train set Test set t-test or χ2
Self-reported baseline characteristics Factor N (%) or mean (S.D.) N (%) or mean (S.D.) p value
Sample size 1772 1136
Age in years Mean (S.D.) 42.1 (14.0) 43.2 (14.3) 0.051
Gender Female 1131 (65.7) 769 (67.8) 0.237
Male 59 (34.3) 365 (32.2)
Ethnicity White 1613 (93.7) 1085 (95.6) 0.028
Non-White 109 (6.33) 50 (4.41)
Employment status Employed 996 (57.8) 643 (56.7) 0.002
Not seeking employment 379 (22.0) 306 (27.0)
Unemployed 347 (20.2) 185 (16.3)
Marital status Married/cohabiting 819 (47.6) 560 (49.3) 0.608
Single 560 (32.5) 351 (30.9)
No longer married 343 (19.9) 225 (19.8)
Number of recent life events Mean (S.D.) 1.39 (1.26) 1.28 (1.20) 0.021
Social support total Median (interquartile range) 21 (18 to 24) 22 (18 to 24) 0.752
AUDIT-PC score Mean (S.D.) 2.57 (2.87) 3.13 (3.26) <0.001
Past antidepressant use No 537 (31.2) 371 (32.7) 0.408
Yes 1185 (68.8) 765 (67.3)
CIS-R Sum of anxiety Subscales score Mean (S.D.) 13.7 (6.85) 13.9 (6.31) 0.437
CIS-R durations Depression 3.38 (1.44) 3.48 (1.25) 0.056
Average anxiety duration 2.14 (1.00) 2.13 (0.97) 0.780
Comorbid anxiety disorders Mean (S.D.) 2.03 (1.17) 2.19 (1.05) 0.0002
Agoraphobia No 1554 (89.7) 991 (87.3) 0.052
Yes 178 (10.3) 144 (12.7)
Chronic fatigue syndrome No 615 (35.7) 348 (30.6) 0.005
Yes 1107 (64.3) 788 (69.4)
Generalised anxiety disorder No 701 (40.7) 492 (43.4) 0.162
Yes 1021 (59.3) 643 (56.7)
Mixed anxiety and depressive disorder No 1241 (72.1) 798 (70.3) 0.292
Yes 481 (27.9) 338 (29.8)
Obsessive compulsive disorder No 1477 (85.8) 962 (84.7) 0.42
Yes 245 (14.2) 174 (15.3)
Panic disorder No 1562 (90.7) 1061 (93.4) 0.01
Yes 160 (9.3) 75 (6.60)
Specific phobias No 1406 (81.7) 967 (85.1) 0.015
Yes 316 (18.4) 169 (14.9)
Baseline BDI-II score Mean (S.D.) 29.5 (11.1) 31.9 (9.45) <0.001
Three–four months BDI-II score Mean (S.D.) 14.4 (11.4) 17.9 (12.4) <0.001
Remission 3–4 months No 742 (51.2) 621 (67.7) <0.001
Yes 708 (48.8) 297 (32.4)
Baseline PROMIS score Mean (S.D.) 70.3 (8.38) 73.3 (6.36) <0.001
Three–four months PROMIS score Mean (S.D.) 60.1 (11.5) 60.4 (12.5) 0.499
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eight CIS-R anxiety subscale scores instead of the sum scores for
each). Any of the eight models could be used to predict the sever-
ity of depressive symptoms at 3–4 months after starting treatment
based on pre-treatment data. The large difference in observed
remission rates between those predicted to have high compared
to low BDI-II scores at 3–4 months informs the potential clinical
relevance of these models.
Strengths and limitations
This study was the first to provide robust tests of the ability of
centrality statistics from FGL networks and factor loadings from
a factor analytic model to develop weighted total scale scores to
inform predictive models of treatment outcomes. This is some-
thing that has been proposed as a promising method for using
individual symptom data to build informative predictive models
(Boschloo et al., 2016). We tested these methods against bone
fide predictive models and simple comparison models, and in
entirely held-out (test) data, and found there to be little evidence
of any advantage to the above approaches. We used a large indi-
vidual patient data dataset comprising six RCTs with a variety of
widely available treatments for depression, all of the RCTs were
situated in primary care, and five were pragmatic trials, increasing
the generalisability of these results (Rothwell, 2005). However, the
variability in the samples between the studies may have limited
the overall performance of the models. We included a range of
psychopathology measures at baseline, not just depression symp-
toms from a single measure, as there is good evidence that such
factors are associated with prognosis for depressed adults
(Buckman et al., 2021a; Buckman et al., 2021b). We also used
the most commonly utilised comprehensive measure of depressive
and anxiety symptoms and diagnoses from RCTs of depression in
primary care, to minimise bias in harmonising data, and ensure a
broad range of depressive and anxiety based symptoms could be
included in the models we developed.
However, there were a number of limitations. Not all import-
ant covariates were controlled for: we did not include data on
durations of depression or anxiety despite their associations
with prognosis for adults with depression (Buckman et al.,
2021a; Lorenzo-Luaces et al., 2020). Including such data would
have led to problems of multi-collinearity with the symptoms of
the individual comorbid anxiety disorders experienced by each
participant, and across durations of anxiety disorders and depres-
sion, biasing centrality estimates and factor loadings for models
1–4. The intercepts and coefficient weights provided in the online
Supplementary materials could be used to derive prognostic pre-
dictions for future depressed patients using models developed
here. However, there were large amounts of variance in the out-
come that could not be explained by any of the models. This is
consistent with other studies that developed and validated pre-
dictive models for patients with depression (Delgadillo, Huey,
Bennett, & McMillan, 2017; Webb et al., 2020). Some of the unex-
plained variance is likely due to measurement error and other fac-
tors, including those that better capture the biopsychosocial
complexity of depression. We speculate that such factors would
need to be included before the predictive models could more
accurately predict prognosis for any individual patient (Fried &
Robinaugh, 2020). Crucially, for this study, such improvements
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in accuracy may also have been required for us to find substantial
differences in the performance of the modelling schemes.
In this study, predictions of prognosis were made regardless of
the type of treatment given, as this may have most utility at the
point when patients are seeking treatment, i.e. before a decision
on the type of treatment has been made (Buckman et al.,
2021a; Marwood, Wise, Perkins, & Cleare, 2018). Although the
train and test set studies were split such that where possible,
there was a balance of treatment types across the datasets, it
may be the case that the models would perform differently
between types of treatments. Future studies might address differ-
ential model performance by treatment type but adequate data to
do so were not available here (Fisher, Carpenter, Morris, Freeman,
& Tierney, 2017b).
The present study used prognostic outcomes including
depressive symptom severity at 3–4 months and remission, but
both of these relied on sum scores from the BDI-II. As the
BDI-II items or sum score were used in the development of the
predictive models it might have been informative to consider
model performance with an entirely separate but clinically mean-
ingful outcome such as functioning, quality of life, or mental pain
(Fava et al., 2019); data on such outcomes were not available here.
In addition, models here used IPD but the networks were esti-
mated based on aggregated data, a number of studies have
shown the potential utility of using idiographic networks to pre-
dict outcomes for individual patients (Fisher & Boswell, 2016;
Fisher, Medaglia, & Jeronimus, 2018; Fisher, Reeves, Lawyer,
Medaglia, & Rubel, 2017a), this may yet prove the most fruitful
avenue for using networks to inform prognostic models which
are able to outperform classic regression models of the same
factors.
Implications and conclusions
Prognoses generated by the models developed here could be
informative for depressed patients seeking treatment in primary
care. However, there were few differences between the models,
with no clear advantage in using individual items over sum scores,
or in using network models or factor analytic models to weight
individual items, in order to derive prognostic predictions. This
may represent a limitation of the available data, or of the model-
ling approaches (that e.g. rely on estimating linear relations). In all
of the models, the degree of inaccuracy in their predictions might
be unacceptable to any individual patient. There were clear differ-
ences in the number of people reaching remission when the mod-
els predicted patients would have particularly low or high scores,
but the models performed less well with BDI-II scores between 18
and 25. It may be informative for future studies to test the utility
in giving more intensive treatments or more regular clinical
reviews for patients with these mid-range scores, particularly if
there is uncertainty about the value of doing so based on clinical
severity. It is noteworthy that all of the models utilised both
depressive and anxiety symptom data, and all but one included
the total score from the life events scale, and six of the eight
included the social support scale score. It might therefore be
informative for prognosis to assess for these factors routinely in
clinic. The individual-item models outperformed the others in
the internal cross-validation data suggesting that narrow con-
structs (e.g. anhedonia) might be more informative for prognosis
than broad constructs (e.g. depression), but issues of measure-
ment error arise, particularly with the validity of the single
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here also highlight the importance of external validation in
accounting for issues of overfitting.
Authors contributions. JEJB, CO’D, ZDC and EF conceived of the original
project, JEJB along with SP, GL, RJD, SDH, SG, TK, EW and GA applied for
and received funding to support this work. All ten of the above and RS wrote
the initial protocol document and plan for the current study. ZDC, NW, DK,
TK, SG and GL provided data and liaison to resolve issues and discrepancies
between received datasets and publications about those studies. JEJB, RS, GL
and SP were responsible for the screening of studies, data extraction, and add-
itional data cleaning. JB, CO’D and ZDC conducted the data analyses with sup-
port from EF, GA, RS, GL and SP, and consultation from all other authors. JEJB
wrote the original manuscript will support from ZDC, RS, CO’D, EF, GA, GL
and SP. All authors contributed to consecutive drafts and approved the final
manuscript. The corresponding author attests that all listed authors meet
authorship criteria and that no others meeting the criteria have been omitted.
Financial support. This work was supported by the Wellcome Trust through
a Clinical Research Fellowship to JEJB (201292/Z/16/Z), MQ Foundation (for
ZDC: MQDS16/72), the Higher Education Funding Council for England, the
National Institute of Health Research (NIHR), NIHR University College
London Hospitals Biomedical Research Centre (CO’D, RS, GL and SP),
NIHR Biomedical Research Centre at the University Hospitals Bristol and
Weston NHS Foundation Trust and the University of Bristol (NW and DK),
University College London (GA, GL), University of Pennsylvania (RJD),
Vanderbilt University (SDH), University of Southampton (TK), University
of Exeter (EW), and University of York (SG), National Institute for Health
Research (NIHR) Biomedical Research Centre at South London and
Maudsley NHS Foundation Trust and King’s College London (TE, AP and
CR). The views expressed are those of the authors and not necessarily those
of the NIHR or the Department of Health and Social Care.
The included studies that make up the Dep-GP IPD database were
funded by:
(1) COBALT: The National Institute for Health Research Health Technology
Assessment (NIHR HTA) programme (project number 06/404/02).
(2) GENPOD: Medical Research Council and supported by the Mental Health
Research Network.
(3) IPCRESS: BUPA Foundation.
(4) MIR: NIHR HTA programme (project 11/129/76) and supported by the
NIHR Biomedical Research Centre at University Hospitals Bristol NHS
Foundation Trust and the University of Bristol.
(5) PANDA: NIHR Programme Grant for Applied Research
(RP-PG-0610-10048).
(6) TREAD: NIHR HTA programme.
The funders of the study had no role in study design, data collection, data
analysis, data interpretation, or writing of the report. All authors were fully
independent of their respective funders and had responsibility for the decision
to submit for this manuscript for publication.
Conflict of interest. None.
Supplementary material. The supplementary material for this article can
be found at https://doi.org/10.1017/S0033291721001616.
References
Adibi, A., Sadatsafavi, M., & Ioannidis, J. P. A. (2020). Validation and utility
testing of clinical prediction models. JAMA, 324(3), 235. https://doi.org/
10.1001/jama.2020.1230.
Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Manual for the Beck
Depression Inventory-II. San Antonio, TX: Psychological Corporation.
Berlim, M. T., Richard-Devantoy, S., Dos Santos, N. R., & Turecki, G. (2020).
The network structure of core depressive symptom-domains in major depres-
sive disorder following antidepressant treatment: a randomized clinical trial.
Psychological Medicine, 1–15. https://doi.org/10.1017/S0033291720001002.
Borsboom, D. (2017). A network theory of mental disorders.World Psychiatry,
16(1), 5–13. https://doi.org/10.1002/wps.20375.
Borsboom, D., & Cramer, A. O. J. (2013). Network analysis: an integrative
approach to the structure of psychopathology. Annual Review of Clinical
Psychology, 9(1), 91–121. https://doi.org/10.1146/annurev-clinpsy-050212-
185608.
Boschloo, L., van Borkulo, C. D., Borsboom, D., & Schoevers, R. A. (2016). A
prospective study on how symptoms in a network predict the onset of
Fig. 2. Proportion of participants in remission at 3–4 months post-baseline in the test set studies (n = 918) by predicted category of depressive severity at 3–4
months, for each of the eight models.
Psychological Medicine 9
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291721001616
Downloaded from https://www.cambridge.org/core. IP address: 82.132.227.10, on 13 May 2021 at 10:33:01, subject to the Cambridge Core terms of use, available at
depression. Psychotherapy and Psychosomatics, 85(3), 183–184. https://doi.
org/10.1159/000442001.
Bower, P., Kontopantelis, E., Sutton, A., Kendrick, T., Richards, D. A., Gilbody,
S.,… Liu, E. T.-H. (2013). Influence of initial severity of depression on effect-
iveness of low intensity interventions: meta-analysis of individual patient
data. BMJ, 346(feb26 2), f540–f540. https://doi.org/10.1136/bmj.f540.
Bringmann, L. F., Elmer, T., Epskamp, S., Krause, R. W., Schoch, D., Wichers,
M., … Snippe, E. (2019). What do centrality measures measure in psycho-
logical networks? Journal of Abnormal Psychology, 128(8), 892–903. https://
doi.org/10.1037/abn0000446.
Buckman, J. E. J., Saunders, R., Cohen, Z. D., Barnett, P., Clarke, K., Ambler,
G.,… Pilling, S. (2021a). The contribution of depressive ’disorder character-
istics’ to determinations of prognosis for adults with depression: an individ-
ual patient data meta-analysis. Psychological Medicine, 1–14. https://doi.org/
10.1017/S0033291721001367.
Buckman, J. E. J., Saunders, R., Cohen, Z. D., Clarke, K., Ambler, G., DeRubeis,
R. J., … Pilling, S. (2020). What factors indicate prognosis for adults with
depression in primary care? A protocol for meta-analyses of individual
patient data using the Dep-GP database. Wellcome Open Research, 4, 69.
https://doi.org/10.12688/wellcomeopenres.15225.3.
Buckman, J. E. J., Saunders, R., O’Driscoll, C., Cohen, Z. D., Stott, J., Ambler,
G., … Pilling, S. (2021b). Is social support pre-treatment associated with
prognosis for adults with depression in primary care? Acta Psychiatrica
Scandinavica, acps.13285. https://doi.org/10.1111/acps.13285.
Buckman, J. E. J., Underwood, A., Clarke, K., Saunders, R., Hollon, S. D.,
Fearon, P., & Pilling, S. (2018). Risk factors for relapse and recurrence of
depression in adults and how they operate: a four-phase systematic review
and meta-synthesis. Clinical Psychology Review, 64(7), 13–38. https://doi.
org/10.1016/j.cpr.2018.07.005.
Choi, S. W., Schalet, B. D., Cook, K. F., & Cella, D. (2014). Establishing a com-
mon metric for depressive symptoms: linking the BDI-II, CES-D, and
PHQ-9 to PROMIS depression. Psychological Assessment, 26(2), 513–527.
https://doi.org/10.1037/a0035768.
Cohen, Z. D., & DeRubeis, R. J. (2018). Treatment selection in depression.
Annual Review of Clinical Psychology, 14(1), 209–236. https://doi.org/10.
1146/annurev-clinpsy-050817-084746.
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. G. M. (2015).
Transparent reporting of a multivariable prediction model for individual
prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMC
Medicine, 13(1), 1–10. https://doi.org/10.1186/s12916-014-0241-z.
Costantini, G., & Epskamp, S. (2017a). Package “EstimateGroupNetwork”. pp.
1–10. CRAN.
Costantini, G., & Epskamp, S. (2017b). Perform the Joint Graphical Lasso and
Selects Tuning Parameters. pp. 1–10. CRAN.
Costantini, G., Richetin, J., Preti, E., Casini, E., Epskamp, S., & Perugini, M.
(2019). Stability and variability of personality networks. A tutorial on recent
developments in network psychometrics. Personality and Individual
Differences, 136, 68–78. https://doi.org/10.1016/j.paid.2017.06.011.
Danaher, P., Wang, P., & Witten, D. M. (2014). for inverse covariance estima-
tion across multiple classes. Journal of the Royal Statistical Society, 76(2),
373–397. https://doi.org/10.1111/rssb.12033.The.
Delgadillo, J., Huey, D., Bennett, H., & McMillan, D. (2017). Case complexity
as a guide for psychological treatment selection. Journal of Consulting and
Clinical Psychology, 85(9), 835–853. https://doi.org/10.1037/ccp0000231.
Driessen, E., Cuijpers, P., Hollon, S. D., & Dekker, J. J. M. (2010). Does
pretreatment severity moderate the efficacy of psychological treatment of
adult outpatient depression? A meta-analysis. Journal of Consulting and
Clinical Psychology, 78(5), 668–680. https://doi.org/10.1037/a0020570.
Dwyer, D. B., Falkai, P., & Koutsouleris, N. (2018).Machine learning approaches
for clinical psychology and psychiatry. Annual Review of Clinical Psychology,
14(1), 91–118. https://doi.org/10.1146/annurev-clinpsy-032816-045037.
Elliott, H., Jones, P. J., & Schmidt, U. (2020). Central symptoms predict post-
treatment outcomes and clinical impairment in anorexia Nervosa: a net-
work analysis. Clinical Psychological Science, 8(1), 139–154. https://doi.
org/10.1177/2167702619865958.
Epskamp, S., & Fried, E. I. (2018). A tutorial on regularized partial correlation
networks. Psychological Methods, 23(4), 617–634. https://doi.org/10.1037/
met0000167.
Fava, G. A., Ruini, C., & Belaise, C. (2007). The concept of recovery in major
depression. Psychological Medicine, 37, 307–317. Retrieved from http://
ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=psyc5&NEWS=
N&AN=2007-03729-001.
Fava, G. A., Tomba, E., Brakemeier, E. L., Carrozzino, D., Cosci, F., Eöry, A.,…
Guidi, J. (2019). Mental pain as a transdiagnostic patient-reported outcome
measure. Psychotherapy and Psychosomatics, 88(6), 341–349. https://doi.org/
10.1159/000504024.
Fischer, H. F., & Rose, M. (2016). Www.common-metrics.org: a web applica-
tion to estimate scores from different patient-reported outcome measures
on a common scale. BMC Medical Research Methodology, 16(142), 1–5.
https://doi.org/10.1186/s12874-016-0241-0.
Fisher, A. J., & Boswell, J. F. (2016). Enhancing the personalization of psycho-
therapy with dynamic assessment and modeling. Assessment, 23(4), 496–
506. https://doi.org/10.1177/1073191116638735.
Fisher, D. J., Carpenter, J. R., Morris, T. P., Freeman, S. C., & Tierney, J. F.
(2017b). Meta-analytical methods to identify who benefits most from treat-
ments: daft, deluded, or deft approach? Most from particular treatments or
other broad approaches used for testing such. BMJ, 356( j573), 1–6. https://
doi.org/10.1136/bmj.j573.
Fisher, A. J.,Medaglia, J.D., & Jeronimus, B. F. (2018). Lackof group-to-individual
generalizability is a threat to human subjects research. Proceedings of the
National Academy of Sciences of the United States of America, 115(27),
E6106–E6115. https://doi.org/10.1073/pnas.1711978115.
Fisher, A. J., Reeves, J. W., Lawyer, G., Medaglia, J. D., & Rubel, J. A. (2017a).
Exploring the idiographic dynamics of mood and anxiety via network ana-
lysis. Journal of Abnormal Psychology, 126(8), 1044–1056. https://doi.org/10.
1037/abn0000311.
Fournier, J. C., Derubeis, R. J., Hollon, S. D., Shelton, R. C., & Fawcett, J.
(2010). Antidepressant drug effects and depression severity. Journal of the
American Medical Association, 303(1), 47–53.
Fried, E. I., & Cramer, A. O. J. (2017). Moving forward: challenges and direc-
tions for psychopathological network theory and methodology. Perspectives
on Psychological Science, 12(6), 999–1020. https://doi.org/10.1177/
1745691617705892.
Fried, E. I., Eidhof, M. B., Palic, S., Costantini, G., Huisman-van Dijk, H. M.,
Bockting, C. L. H., … Karstoft, K.-I. (2018). Replicability and generalizabil-
ity of posttraumatic stress disorder (PTSD) networks: a cross-cultural
multisite study of PTSD symptoms in four trauma patient samples.
Clinical Psychological Science, 6(3), 335–351. https://doi.org/10.1177/
2167702617745092.
Fried, E. I., Epskamp, S., Nesse, R. M., Tuerlinckx, F., & Borsboom, D. (2016).
What are “good” depression symptoms? Comparing the centrality of DSM
and non-DSM symptoms of depression in a network analysis. Journal of
Affective Disorders, 189, 314–320. https://doi.org/10.1016/j.jad.2015.09.005.
Fried, E. I., & Nesse, R. M. (2014). The impact of individual depressive symp-
toms on impairment of psychosocial functioning. PLoS ONE, 9(2), e90311.
https://doi.org/10.1371/journal.pone.0090311.
Fried, E. I., & Nesse, R. M. (2015a). Depression is not a consistent syndrome: an
investigation of unique symptom patterns in the STAR*D study. Journal of
Affective Disorders, 172, 96–102. https://doi.org/10.1016/j.jad.2014.10.010.
Fried, E. I., & Nesse, R. M. (2015b). Depression sum-scores don’t add up: why
analyzing specific depression symptoms is essential. BMC Medicine, 13(1),
72. https://doi.org/10.1186/s12916-015-0325-4.
Fried, E. I., & Robinaugh, D. J. (2020). Systems all the way down: embracing
complexity in mental health research. BMC Medicine, 18(1), 4–7. https://
doi.org/10.1186/s12916-020-01668-w.
Friedman, J., Hastie, T., & Tibshirani, R. (2010). Regularization paths for gen-
eralized linear models via coordinate descent. Journal of Statistical Software,
33(1), 1–22. https://doi.org/10.18637/jss.v033.i01.
Harrell, F. E., Lee, K. L., & Mark, D. B. (2004). Prognostic/clinical prediction
models: multivariable prognostic models: issues in developing models,
evaluating assumptions and adequacy, and measuring and reducing
errors. Tutorials in Biostatistics: Statistical Methods in Clinical
Studies, 1, 223–249. https://doi.org/10.1002/0470023678.ch2b(i).
Hayden, J. A., Windt Van Der, D. A., Cartwright, J. L., Côté, P., & Bombardier,
C. (2013). Assessing bias in studies of prognostic factors. Annals of Internal
Medicine, 158, 280–286.
10 J. E. J. Buckman et al.
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0033291721001616
Downloaded from https://www.cambridge.org/core. IP address: 82.132.227.10, on 13 May 2021 at 10:33:01, subject to the Cambridge Core terms of use, available at
Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., …
Keller, M. B. (1998). Major depressive disorder: a prospective study of
residual subthreshold depressive symptoms as predictor of rapid relapse.
Journal of Affective Disorders, 50(2–3), 97–108. https://doi.org/10.1016/
S0165-0327(98)00138-4.
Koenders, M. A., De Kleijn, R., Giltay, E. J., Elzinga, B. M., Spinhoven, P., &
Spijker, A. T. (2015). A network approach to bipolar symptomatology in
patients with different course types. PLoS ONE, 10(10), 1–16. https://doi.
org/10.1371/journal.pone.0141420.
Letina, S., Blanken, T. F., Deserno, M. K., & Borsboom, D. (2019). Expanding
network analysis tools in psychological networks: minimal spanning
trees, participation coefficients, and motif analysis applied to a network
of 26 psychological attributes. Complexity, 2019. https://doi.org/10.1155/
2019/9424605.
Lewis, G., Pelosi, A. J., Araya, R., & Dunn, G. (1992). Measuring psychiatric
disorder in the community: a standardized assessment for use by lay inter-
viewers. Psychological Medicine, 22, 465–486.
Lorenzo-Luaces, L., Rodriguez-Quintana, N., & Bailey, A. J. (2020). Double
trouble: do depression severity and duration interact to predicting treatment
outcomes in adolescent depression? Behaviour Research and Therapy, 131,
103637. https://doi.org/10.1016/j.brat.2020.103637.
Marwood, L., Wise, T., Perkins, A. M., & Cleare, A. J. (2018). Meta-analyses
of the neural mechanisms and predictors of response to psycho-
therapy in depression and anxiety. Neuroscience and Biobehavioral
Reviews, 95(September), 61–72. https://doi.org/10.1016/j.neubiorev.2018.
09.022.
Moons, K. G. M., Altman, D. G., Reitsma, J. B., Ioannidis, J. P. A., Macaskill,
P., Steyerberg, E. W., … Collins, G. S. (2015). Transparent reporting of a
multivariable prediction model for individual prognosis or diagnosis
(TRIPOD): explanation and elaboration. Annals of Internal Medicine, 162
(1), W1. https://doi.org/10.7326/M14-0698.
Morgan, A. J., Reavley, N. J., & Jorm, A. F. (2014). Beliefs about mental
disorder treatment and prognosis: comparison of health professionals
with the Australian public. Australian and New Zealand Journal of
Psychiatry, 48(5), 442–451. https://doi.org/10.1177/0004867413512686.
O’Driscoll, C., Buckman, J. E. J., Fried, E. I., Saunders, R., Cohen, Z. D.,
Ambler, G., … Pilling, S. (2021). The importance of transdiagnostic symp-
tom level assessment to understanding prognosis for depressed adults: ana-
lysis of data from six randomized control trials. BMC Medicine, 1–21.
https://doi.org/10.1186/s12916-021-01971-0.
Robinaugh, D. J., Hoekstra, R. H. A., Toner, E. R., & Borsboom, D. (2020). The
network approach to psychopathology: a review of the literature 2008–2018
and an agenda for future research. Psychological Medicine, 50(3), 353–366.
https://doi.org/10.1017/S0033291719003404.
Robinaugh, D. J., Millner, A. J., & McNally, R. J. (2016). Identifying highly
influential nodes in the complicated grief network. Journal of Abnormal
Psychology, 125(6), 747–757. https://doi.org/10.1002/cncr.27633.Percutaneous.
Rothwell, P. M. (2005). Subgroup analysis in randomised controlled trials:
Importance, indications, and interpretation. Lancet, 365, 176–186.
Stekhoven, D. J. & Bühlmann, P. (2012). Missforest-non-parametric missing
value imputation for mixed-type data. Bioinformatics, 28, 112–118.
Steyerberg, E. W., Vickers, A. J., Cook, N. R., Gerds, T., Gonen, M., Obuchowski,
N.,… Kattan, M. W. (2010). Assessing the performance of prediction models.
Epidemiology, 21(1), 128–138. https://doi.org/10.1097/EDE.0b013e3181c30fb2.
Thornicroft, G., Chatterji, S., Evans-Lacko, S., Gruber, M., Sampson, N.,
Aguilar-Gaxiola, S., … Kessler, R. C. (2017). Undertreatment of people
with major depressive disorder in 21 countries. British Journal of
Psychiatry, 210(2), 119–124. https://doi.org/10.1192/bjp.bp.116.188078.
van Borkulo, C., Boschloo, L., Borsboom, D., Penninx, B. W. J. H., Waldorp, L.
J., & Schoevers, R. A. (2015). Association of symptom network structure
with the course of depression. JAMA Psychiatry, 72(12), 1219. https://doi.
org/10.1001/jamapsychiatry.2015.2079.
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., …
Coggeshall, M. (2016). Global, regional, and national incidence, prevalence,
and years lived with disability for 310 diseases and injuries, 1990–2015: a
systematic analysis for the global burden of disease study 2015. Lancet,
388, 1545–1602. https://doi.org/10.1016/S0140-6736(16)31678-6.
Webb, C. A., Cohen, Z. D., Beard, C., Forgeard, M., Peckham, A. D., &
Björgvinsson, T. (2020). Personalized prognostic prediction of treatment
outcome for depressed patients in a naturalistic psychiatric hospital setting:
a comparison of machine learning approaches. Journal of Consulting and
Clinical Psychology, 88(1), 25–38. https://doi.org/10.1037/ccp0000451.
Weitz, E. S., Hollon, S. D., Twisk, J., Van Straten, A., Huibers, M. J. H., David,
D., … Cuijpers, P. (2015). Baseline depression severity as moderator of
depression outcomes between cognitive behavioral therapy vs pharmaco-
therapy: an individual patient data meta-analysis. JAMA Psychiatry, 72
(11), 1102–1109. https://doi.org/10.1001/jamapsychiatry.2015.1516.
Wichers, M., & Groot, P. C. (2016). Critical slowing down as a personalized




Downloaded from https://www.cambridge.org/core. IP address: 82.132.227.10, on 13 May 2021 at 10:33:01, subject to the Cambridge Core terms of use, available at
